Dawnrays Pharma (02348) announced interim results: 截至二零二六年六月三十日止六個月之中期業績公佈, net profit attributable to owners RMB1.2bn Title: 截至二零二六年六月三十日止六個月之中期業績公佈 Revenue: RMB5.5bn Net profit: RMB1.2bn Profit attributable to owners: RMB1.2bn
